A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to facilitate the use of state-of-the-art machine learning-based algorithms that utilize databases and images with the purpose of identifying early stages of pancreatic cancer, as well as people at high-risk.The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC.

Eligibility criteria

Qualifiers

Age ≥ 18 year

Able to provide written informed consent

Meets criteria as a High-Risk Individual as defined by protocol

Disqualifiers

Individual who has a personal history of pancreatic ductal adenocarcinoma (PDAC)

History of total pancreatectomy

Trial design

Treatments tested in this trial

  • Bio-specimen Collection: Blood
  • Bio-specimen Collection: Pancreatic Juice
  • MRI

Treatment groups

5,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators